Recent work has also shown that, by obstructing CGRP- mediated IL-23 production from psoriatic dendritic cells, lidocaine has the ability to ameliorate IMQ-induced psoriasis-like skin inflammation [58]. This evidence concerns the gene CALCA and psoriasis.